Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.

Ringdén, O

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases. [electronic resource] - Bone marrow transplantation Apr 2007 - 383-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0268-3369

10.1038/sj.bmt.1705602 doi


Adolescent
Adult
Anemia, Aplastic--therapy
Antineoplastic Agents--pharmacology
Child
Child, Preschool
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation--methods
Hemoglobinopathies--therapy
Humans
Immunologic Deficiency Syndromes--therapy
Infant
Male
Middle Aged
Transplantation Conditioning
Vidarabine--analogs & derivatives